Viprakasit Vip, Ekwattanakit Supachai
Siriraj Integrated Center of Excellence for Thalassemia (SiiCOE-T) and Division of Hematology/Oncology, Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Siriraj, Bangkoknoi, Bangkok 10700, Thailand.
Division of Hematology, Department of Medicine, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Siriraj, Bangkoknoi, Bangkok 10700, Thailand.
Hematol Oncol Clin North Am. 2018 Apr;32(2):193-211. doi: 10.1016/j.hoc.2017.11.006.
At present, thalassemia diseases are classified into transfusion-dependent thalassemia and non-transfusion-dependent thalassemia. This classification is based on the clinical severity of patients determining whether they do require regular blood transfusions to survive (transfusion-dependent thalassemia) or not (non-transfusion-dependent thalassemia). In addition to the previous terminology of "thalassemia major" or "thalassemia intermedia," this classification has embraced all other forms of thalassemia syndromes such as α-thalassemia, hemoglobin E/β-thalassemia and combined α- and β-thalassemias. Definitive diagnosis of thalassemia and hemoglobinopathies requires a comprehensive workup from complete blood count, hemoglobin analysis, and molecular studies to identify mutations of globin genes.
目前,地中海贫血疾病分为依赖输血的地中海贫血和非依赖输血的地中海贫血。这种分类是基于患者的临床严重程度来确定他们是否确实需要定期输血以维持生命(依赖输血的地中海贫血)或不需要(非依赖输血的地中海贫血)。除了以前的“重型地中海贫血”或“中间型地中海贫血”术语外,这种分类还涵盖了所有其他形式的地中海贫血综合征,如α地中海贫血、血红蛋白E/β地中海贫血以及α和β地中海贫血合并症。地中海贫血和血红蛋白病的明确诊断需要从全血细胞计数、血红蛋白分析以及分子研究等方面进行全面检查,以识别珠蛋白基因的突变。